Empirical Asset Management, LLC Harvard Bioscience Inc Transaction History

Empirical Asset Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Oct 19, 2022	BUY	$2.33 - $3.92 $23,300 - $39,200	10,000 Added 100.0%	20,000 $51,000
Q2 2022 Jul 18, 2022	BUY	$3.28 - $6.42 $32,800 - $64,200	10,000 New	10,000 $36,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Empirical Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Empirical Asset Management, LLC with notifications on news.